When it comes to risk assessment and diagnosis of prenatal aneuploidy and pre-eclampsia, early detection is essential. Accurate results, based on clinically validated assays, give women the confidence they need to plan and manage their pregnancies without unnecessary uncertainty or distress.

PerkinElmer Genomics Sweden supports laboratories and clinics with optimized screening programs for various pregnancy complica­tions. By increasing access to high-quality, fast and affordable results, we aim to improve the level of prenatal care globally.